| Product Code: ETC7177355 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji continued to heavily rely on imports of hemostatic agents, with top exporting countries being Australia, China, New Zealand, Hong Kong, and the UK. Despite the high concentration of imports, the market experienced a significant compound annual growth rate (CAGR) of 24.47% from 2020 to 2024. However, there was a notable decline in growth rate from 2023 to 2024 at -29.08%, indicating a potential shift in market dynamics during that period. Fiji`s dependency on these key exporting nations highlights the importance of monitoring trade relationships and market trends in the hemostatic agents sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Hemostatic Agents Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Hemostatic Agents Market - Industry Life Cycle |
3.4 Fiji Hemostatic Agents Market - Porter's Five Forces |
3.5 Fiji Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Fiji Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Fiji Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in Fiji |
4.2.2 Growing awareness about the benefits of hemostatic agents in reducing blood loss during surgeries |
4.2.3 Technological advancements leading to the development of more efficient hemostatic agents |
4.3 Market Restraints |
4.3.1 High cost associated with hemostatic agents |
4.3.2 Limited availability of skilled healthcare professionals in Fiji |
4.3.3 Stringent regulatory requirements for approval of hemostatic agents |
5 Fiji Hemostatic Agents Market Trends |
6 Fiji Hemostatic Agents Market, By Types |
6.1 Fiji Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Fiji Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Fiji Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Fiji Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Fiji Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Fiji Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Fiji Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Fiji Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Fiji Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Fiji Hemostatic Agents Market Export to Major Countries |
7.2 Fiji Hemostatic Agents Market Imports from Major Countries |
8 Fiji Hemostatic Agents Market Key Performance Indicators |
8.1 Average length of hospital stay post-surgery |
8.2 Number of surgical procedures utilizing hemostatic agents |
8.3 Adoption rate of advanced hemostatic technologies |
9 Fiji Hemostatic Agents Market - Opportunity Assessment |
9.1 Fiji Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Fiji Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Fiji Hemostatic Agents Market - Competitive Landscape |
10.1 Fiji Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Fiji Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |